BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25422423)

  • 1. Structural basis of collagen fiber degradation by cathepsin K.
    Aguda AH; Panwar P; Du X; Nguyen NT; Brayer GD; Brömme D
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17474-9. PubMed ID: 25422423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of basic amino acid surface clusters on the collagenase activity of cathepsin K.
    Nallaseth FS; Lecaille F; Li Z; Brömme D
    Biochemistry; 2013 Nov; 52(44):7742-52. PubMed ID: 24088021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An allosteric site enables fine-tuning of cathepsin K by diverse effectors.
    Novinec M; Rebernik M; Lenarčič B
    FEBS Lett; 2016 Dec; 590(24):4507-4518. PubMed ID: 27859061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of collagenase activities of human cathepsins by glycosaminoglycans.
    Li Z; Yasuda Y; Li W; Bogyo M; Katz N; Gordon RE; Fields GB; Brömme D
    J Biol Chem; 2004 Feb; 279(7):5470-9. PubMed ID: 14645229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.
    Li Z; Hou WS; Escalante-Torres CR; Gelb BD; Bromme D
    J Biol Chem; 2002 Aug; 277(32):28669-76. PubMed ID: 12039963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The collagenolytic activity of cathepsin K is unique among mammalian proteinases.
    Garnero P; Borel O; Byrjalsen I; Ferreras M; Drake FH; McQueney MS; Foged NT; Delmas PD; Delaissé JM
    J Biol Chem; 1998 Nov; 273(48):32347-52. PubMed ID: 9822715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel roles of glycosaminoglycans in the degradation of type I collagen by cathepsin K.
    Tatara Y; Suto S; Itoh K
    Glycobiology; 2017 Dec; 27(12):1089-1098. PubMed ID: 29029096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope.
    Atley LM; Mort JS; Lalumiere M; Eyre DR
    Bone; 2000 Mar; 26(3):241-7. PubMed ID: 10709996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin K: a unique collagenolytic cysteine peptidase.
    Novinec M; Lenarčič B
    Biol Chem; 2013 Sep; 394(9):1163-79. PubMed ID: 23629523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation.
    Hou WS; Li Z; Büttner FH; Bartnik E; Brömme D
    Biol Chem; 2003 Jun; 384(6):891-7. PubMed ID: 12887056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided protein engineering of human cathepsin L for efficient collagenolytic activity.
    Choudhury D; Biswas S
    Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 33825882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational flexibility and allosteric regulation of cathepsin K.
    Novinec M; Kovacic L; Lenarcic B; Baici A
    Biochem J; 2010 Jul; 429(2):379-89. PubMed ID: 20450492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex.
    Li Z; Kienetz M; Cherney MM; James MN; Brömme D
    J Mol Biol; 2008 Oct; 383(1):78-91. PubMed ID: 18692071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.
    Kafienah W; Brömme D; Buttle DJ; Croucher LJ; Hollander AP
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):727-32. PubMed ID: 9560298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of substrate-specific inhibitors of cathepsin K through high-throughput screening.
    Law S; Du X; Panwar P; Honson NS; Pfeifer T; Roberge M; Brömme D
    Biochem J; 2019 Feb; 476(3):499-512. PubMed ID: 30622151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates.
    Li Z; Hou WS; Brömme D
    Biochemistry; 2000 Jan; 39(3):529-36. PubMed ID: 10642177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin S cannibalism of cathepsin K as a mechanism to reduce type I collagen degradation.
    Barry ZT; Platt MO
    J Biol Chem; 2012 Aug; 287(33):27723-30. PubMed ID: 22730330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.
    Wilson S; Hashamiyan S; Clarke L; Saftig P; Mort J; Dejica VM; Brömme D
    Am J Pathol; 2009 Nov; 175(5):2053-62. PubMed ID: 19834056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
    Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
    J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of the collagenase activity of cathepsin K.
    Selent J; Kaleta J; Li Z; Lalmanach G; Brömme D
    J Biol Chem; 2007 Jun; 282(22):16492-501. PubMed ID: 17426030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.